Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MED

Medifast Inc

May 26 • 04:00PM ET

13.09

+0.50 3.97 %

Consumer Cyclical • Personal Services • USA • Micro • NYSE

Today, 4:40 PMMedifast formally appoints President Nicholas Johnson as Chief Executive Officer effective June 1, 2026, succeeding Dan Chard who will remain Chairman of the Board.

Peers: WW HLF LFMD NHTC USNA

| Held by: FNDA VTI IWM AVUV SMLF VDC VXF IWN SVAL DFSV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.82	Insider Own	5.42%	Shs Outstand	11.12M	Perf Week	5.14%
Market Cap	145.55M	Forward P/E	-	EPS next Y	-0.60	Insider Trans	3.91%	Shs Float	10.52M	Perf Month	17.40%
Enterprise Value	-7.30M	PEG	-	EPS next Q	-0.65	Inst Own	83.97%	Short Float	19.32%	Perf Quarter	24.90%
Income	-20.02M	P/S	0.42	EPS this Y	-208.33%	Inst Trans	1.06%	Short Ratio	8.67	Perf Half Y	25.62%
Sales	346.10M	P/B	0.74	EPS next Y	67.57%	ROA	-7.53%	Short Interest	2.03M	Perf YTD	22.57%
Book/sh	17.78	P/C	0.86	EPS next 5Y	-	ROE	-9.80%	52W High	15.46 -15.33%	Perf Year	-2.39%
Cash/sh	15.19	P/FCF	-	EPS past 3/5Y	- -	ROIC	-9.54%	52W Low	9.22 41.97%	Perf 3Y	-84.06%
Dividend Est.	-	EV/EBITDA	-18.25	Sales past 3/5Y	-37.74% -16.22%	Gross Margin	70.12%	Volatility	4.26% 5.29%	Perf 5Y	-96.04%
Dividend TTM	-	EV/Sales	-0.02	EPS Y/Y TTM	-184.77%	Oper. Margin	-4.06%	ATR (14)	0.52	Perf 10Y	-61.98%
Dividend Ex-Date	Sep 18, 2023	Quick Ratio	4.30	Sales Y/Y TTM	-36.31%	Profit Margin	-5.78%	RSI (14)	71.58	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.80	EPS Q/Q	-173.48%	SMA20	7.47%	Beta	0.63	Target Price	12.00
Payout	-	Debt/Eq	0.08	Sales Q/Q	-34.29%	SMA50	18.06%	Rel Volume	1.55	Prev Close	12.59
Employees	380	LT Debt/Eq	0.06	Earnings	May 04 AMC	SMA200	10.45%	Avg Volume	234.37K	Price	13.09
IPO	Dec 30, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	63.46% 9.89%	Trades		Volume	364,348	Change	3.97%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-05-24	Upgrade	DA Davidson	Underperform → Neutral	$16.50 → $17
Jun-05-24	Downgrade	DA Davidson	Neutral → Underperform	$25 → $17.50
Oct-13-23	Initiated	Stephens	Equal-Weight	$82
Nov-04-22	Downgrade	DA Davidson	Buy → Neutral	$278 → $106
Aug-04-22	Downgrade	Jefferies	Buy → Hold	$345 → $150
Jan-25-21	Upgrade	Jefferies	Hold → Buy	$205 → $265
Nov-05-20	Upgrade	DA Davidson	Neutral → Buy	$180 → $205
Jun-25-20	Initiated	B. Riley FBR	Buy	$164
Feb-27-20	Downgrade	Jefferies	Buy → Hold	$130 → $90
Nov-08-19	Downgrade	Dougherty & Company	Buy → Neutral
Jul-25-19	Initiated	Jefferies	Buy	$130
Nov-08-18	Upgrade	Sidoti	Neutral → Buy
Mar-07-18	Upgrade	Sidoti	Neutral → Buy
Sep-15-17	Reiterated	DA Davidson	Buy	$65 → $74
Aug-04-16	Reiterated	Wunderlich	Hold	$32 → $36
Jan-11-16	Upgrade	Sidoti	Neutral → Buy
Nov-30-15	Downgrade	Sidoti	Buy → Neutral
Oct-05-15	Upgrade	Sidoti	Neutral → Buy
Nov-07-14	Downgrade	Imperial Capital	Outperform → In-line	$34 → $32
Aug-08-14	Reiterated	Imperial Capital	Outperform	$36 → $34

Show Previous Ratings

Today 04:05PM	Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer (Business Wire)
May-21-26 07:00AM	Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes (GlobeNewswire)
07:00AM	The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do (GlobeNewswire)
May-15-26 01:00PM	Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation (GlobeNewswire)
01:00PM	Peer-Reviewed Research Is Redefining Weight Loss Program Standards (GlobeNewswire)
08:25PM	Loading…
May-04-26 08:25PM	Medifast, Inc. Q1 2026 Earnings Call Summary (Moby) +22.48%
04:24PM	Medifast: Q1 Earnings Snapshot (Associated Press)
04:05PM	Medifast Announces First Quarter 2026 Financial Results (Business Wire)
Apr-20-26 04:05PM	Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026 (Business Wire)
Mar-20-26 08:30AM	Medifast Announces Cooperation Agreement with Steamboat Capital (Business Wire)
Mar-10-26 02:20PM	Newell's Productivity Plan & Other Strategies to Bolster Growth (Zacks)
01:33PM	Hims and Hers Expands Consumer-Focused Digital Health Platform (Zacks)
Mar-06-26 11:24AM	Is Clorox's International Expansion Key to Its Long-Term Success? (Zacks)
Mar-05-26 12:19PM	Brown-Forman's Q3 Earnings Beat Mark, Organic Sales Rise 1% Y/Y (Zacks)
11:24AM	Monster Beverage's Stock Falls 9% Post Q4 Earnings: What to Know? (Zacks)
09:50AM	Loading…
09:50AM	Can Post Holdings Sustain Growth on Foodservice Strength? (Zacks)
Feb-26-26 12:39PM	Diageo 1H'26 Earnings & Sales Decline Y/Y, Organic Sales Drop 2.8% (Zacks)
Feb-25-26 10:11AM	Boston Beer's Q4 Loss Narrows, Lower Volumes Hurt Revenues (Zacks)
Feb-24-26 12:11PM	Freshpet Stock Up 5% After Reporting Q4 Earnings Beat Estimates (Zacks)
12:35AM	Medifast's Q4 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Feb-20-26 08:30AM	Scientific Evidence Demonstrates OPTAVIA's Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients (Business Wire)
Feb-18-26 08:02PM	Medifast Inc (MED) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:16AM	Medifast Q4 Loss Wider Than Expected, Revenues Decline 37% Y/Y (Zacks)
08:30AM	Medifast, Inc. Q4 2025 Earnings Call Summary (Moby)
08:00AM	MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains (StockStory)
Feb-17-26 07:00PM	Medifast Q4 Earnings Call Highlights (MarketBeat)
05:30PM	Medifast (MED) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:44PM	Medifast: Q4 Earnings Snapshot (Associated Press Finance)
04:24PM	Medifast's (NYSE:MED) Q4 CY2025 Sales Top Estimates (StockStory)
04:05PM	Medifast Announces Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
12:23PM	Loading…
12:23PM	Pricing vs. Volume: Can Colgate Balance Growth in a Soft Market? (Zacks)
Feb-15-26 10:05PM	Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow (StockStory)
Feb-13-26 09:06AM	Medifast's Q4 Earnings on Deck: What Could Shape MED's Results? (Zacks)
Feb-12-26 12:56PM	Q2 Deep Dive: Evaluating Clorox's Financial and Operating Metrics (Zacks)
12:08PM	OTLY Stock Gains 11% Despite Reporting Wider-Than-Expected Loss (Zacks)
10:00AM	Celsius Holdings Inc. (CELH) Earnings Expected to Grow: What to Know Ahead of Q4 Release (Zacks)
09:59AM	Hims & Hers Strengthens Integrated Personalized Digital Care Platform (Zacks)
09:18AM	Darling Ingredients' Q4 Earnings and Sales Surpass Estimates (Zacks)
07:40AM	Utz Brands (UTZ) Q4 Earnings Match Estimates (Zacks)
Feb-10-26 11:18AM	HAIN Stock Falls 20% After Reporting Q2 Loss & Y/Y Sales Decline (Zacks)
10:00AM	Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-09-26 10:44AM	Is Nutrition Still a Growth Engine for ADM Amid Demand Shifts? (Zacks)
Feb-06-26 10:22AM	Post Holdings Q1 Earnings Beat Estimates, Sales Grow About 10% Y/Y (Zacks)
Feb-04-26 11:49AM	Will Strategic Pricing Shield Monster Beverage From Rising Costs? (Zacks)
08:36AM	Clorox Q2 Earnings Miss Estimates, Lower Organic Sales Hurt (Zacks)
Feb-03-26 04:05PM	Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025 (Business Wire)
10:21AM	HAIN to Divest North American Snacks Business to Focus on Core Areas (Zacks)
08:10AM	BellRing Brands (BRBR) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
Feb-01-26 11:31PM	3 Stocks Under $50 We Approach with Caution (StockStory)
Jan-29-26 11:36PM	1 of Wall Street's Favorite Stock to Target This Week and 2 We Question (StockStory)
Jan-22-26 12:30PM	Medifast's Q4 Guidance Remains Weak: When Does Growth Return? (Zacks)
Jan-19-26 12:10PM	The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings (PR Newswire)
Jan-16-26 08:30AM	People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA (Business Wire)
Jan-15-26 08:30AM	OPTAVIA Premieres Second Docuseries Episode "Health by Design: Spain" Exploring Metabolic Health and Longevity (Business Wire)
Jan-13-26 11:05PM	3 Reasons to Avoid MED and 1 Stock to Buy Instead (StockStory)
Jan-12-26 10:00AM	Hims & Hers Expands Platform-Led Access to Provider-Directed Care (Zacks)
Jan-08-26 12:52PM	Medifast Shifts to Metabolic Health: A Durable Growth Path? (Zacks)
Jan-05-26 09:00AM	Medifast Announces Planned Leadership Transition (Business Wire) +5.29%
Dec-30-25 12:40PM	Medifast New Product Line Planned: Can Innovation Reignite Demand? (Zacks)
Dec-24-25 12:41PM	Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near? (Zacks)
Dec-23-25 11:45AM	Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows (Zacks)
Dec-18-25 11:48AM	Can Medifast Overcome GLP-1 Pressure With Its Growth Strategy? (Zacks)
Dec-17-25 10:37PM	Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks (StockStory)
Dec-09-25 08:30AM	OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing (Business Wire)
Dec-08-25 02:21PM	Why Medifast (MED) Stock Is Up Today (StockStory)
Dec-05-25 08:44AM	Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves (Zacks)
Dec-02-25 11:39PM	3 Stocks Under $50 We're Skeptical Of (StockStory)
Nov-25-25 12:28PM	Hims & Hers Expands Care Scope as Digital Health Platforms Evolve (Zacks)
Nov-24-25 08:48AM	3 Small-Cap Stocks That Fall Short (StockStory)
Nov-21-25 06:37AM	3 Unprofitable Stocks That Fall Short (StockStory)
Nov-13-25 04:30PM	Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference (Business Wire)
Nov-10-25 12:33AM	5 Insightful Analyst Questions From Medifast's Q3 Earnings Call (StockStory)
Nov-04-25 11:16AM	Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y (Zacks)
08:41AM	MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges (StockStory)
12:00AM	Medifast Inc (MED) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-03-25 05:10PM	Medifast: Q3 Earnings Snapshot (Associated Press Finance)
04:36PM	Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates (StockStory)
04:05PM	Medifast Announces Third Quarter 2025 Financial Results (Business Wire)
Nov-01-25 11:02PM	Medifast Earnings: What To Look For From MED (StockStory)
Oct-31-25 01:58PM	Hims & Hers Scales AI-Driven Personalized Health and Wellness (Zacks)
Oct-30-25 12:40AM	2 Cash-Heavy Stocks Worth Your Attention and 1 We Avoid (StockStory)
Oct-27-25 08:30AM	Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization (Business Wire)
Oct-21-25 10:00AM	Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025 (Business Wire)
Oct-07-25 12:34AM	2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm (StockStory)
Oct-03-25 09:58AM	Hims & Hers Expands Health Access Through Subscription Revenue Model (Zacks)
Oct-02-25 12:28AM	3 Reasons MED is Risky and 1 Stock to Buy Instead (StockStory)
12:05AM	3 Reasons to Avoid MED and 1 Stock to Buy Instead (StockStory)
Sep-19-25 09:48AM	Will Medifast's Strategic Endeavors Deliver Growth in 2025? (Zacks)
Sep-15-25 08:30AM	Evidence Links 5 & 1 Plan to Improved Metabolic Health Outcomes (Business Wire)
Sep-03-25 11:30AM	Medifast (MED) Up 6.5% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-02-25 01:11PM	HIMS' Personalized Wellness Platform Expands Preventive Care Access (Zacks)
Aug-22-25 02:56PM	Why Medifast (MED) Stock Is Trading Up Today (StockStory) +5.31%
Aug-21-25 11:32PM	Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment (StockStory)
Aug-19-25 12:24PM	Medifast Bolsters Growth Through Health & Wellness Solutions (Zacks) +5.75%
Aug-12-25 11:12PM	MED Q2 Deep Dive: Ongoing Coach Decline and GLP-1 Integration Shape Outlook (StockStory)
11:10PM	5 Insightful Analyst Questions From Medifast's Q2 Earnings Call (StockStory)
01:51PM	Medifast (MED) Stock Trades Up, Here Is Why (StockStory)
Aug-07-25 10:51AM	Hims & Hers Redefines Virtual Care With Integrated Tech Platforms (Zacks)
Aug-05-25 12:42PM	Why Medifast (MED) Stock Is Up Today (StockStory)
11:34AM	Medifast's Q2 Earnings Beat Estimates, Lower Revenues Hurt Margins (Zacks)

Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. It offers and ships OPTAVIA products directly to its customers. It focuses on coaching healthy habits through a health transformational system. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.

Executive Chairman & CEOMr. Daniel R. Chard

Chief Field Operations Officer & PresidentMr. Nicholas M. Johnson

Chief Financial OfficerMr. James P. Maloney CPA

Executive VPMr. Jason L. Groves Esq.

VP of Finance & Chief Accounting OfficerMr. Jonathan Barrett MacKenzie

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHLACKMAN SCOTT	Director	May 08 '26	Buy	12.65	2,500	31,625	28,049	May 12 07:10 PM
SCHLACKMAN SCOTT	Director	May 11 '26	Buy	12.53	2,500	31,325	30,549	May 12 07:10 PM
Chard Daniel R	Chairman & CEO	Mar 20 '26	Buy	10.11	17,678	178,725	17,678	Mar 27 05:51 PM
Chard Daniel R	Chairman & CEO	Jun 13 '25	Buy	13.13	381	5,003	149,698	Jun 17 06:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MED

Medifast Inc

Upgrade your Finviz experience